Cubist Systematic Strategies, LLC Athersys, Inc Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.18 - $0.86 $4,244 - $20,279	23,581 New	23,581 $6,000
Q1 2022 May 16, 2022	SELL	$0.6 - $1.06 $23,653 - $41,788	-39,423 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.4 $33,509 - $55,192	39,423 New	39,423 $36,000
Q3 2020 Nov 16, 2020	SELL	$1.91 - $3.08 $55,859 - $90,077	-29,246 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.97 - $3.98 $34,762 - $70,231	17,646 Added 152.12%	29,246 $81,000
Q1 2020 May 15, 2020	BUY	$1.17 - $3.0 $13,572 - $34,800	11,600 New	11,600 $35,000
Q4 2018 Feb 14, 2019	SELL	$1.41 - $2.16 $30,078 - $46,077	-21,332 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$1.86 - $2.18 $19,284 - $22,602	-10,368 Reduced 32.71%	21,332 $45,000
Q2 2018 Aug 14, 2018	BUY	$1.76 - $2.79 $55,792 - $88,443	31,700 New	31,700 $62,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.